Wade G W & Inc. Has $223,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Wade G W & Inc. reduced its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 15.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,886 shares of the company’s stock after selling 519 shares during the quarter. Wade G W & Inc.’s holdings in GE HealthCare Technologies were worth $223,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of GEHC. First Command Advisory Services Inc. raised its position in shares of GE HealthCare Technologies by 36,900.0% during the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after acquiring an additional 369 shares during the last quarter. OFI Invest Asset Management bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at $26,000. ORG Partners LLC raised its position in shares of GE HealthCare Technologies by 174.2% during the 3rd quarter. ORG Partners LLC now owns 425 shares of the company’s stock valued at $29,000 after acquiring an additional 270 shares during the last quarter. Fortitude Family Office LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $29,000. Finally, Turtle Creek Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $30,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Citigroup upped their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Mizuho lowered their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Evercore ISI upped their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. HSBC assumed coverage on shares of GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective for the company. Finally, Morgan Stanley upped their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $94.80.

GE HealthCare Technologies Stock Down 0.5 %

Shares of GE HealthCare Technologies stock traded down $0.42 during trading hours on Friday, reaching $80.89. 348,690 shares of the company’s stock were exchanged, compared to its average volume of 3,305,985. The company has a 50 day moving average of $86.31 and a two-hundred day moving average of $79.95. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The stock has a market cap of $36.92 billion, a P/E ratio of 23.77, a P/E/G ratio of 2.95 and a beta of 1.26.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same period in the prior year, the business posted $0.85 EPS. The company’s quarterly revenue was down 1.2% on a year-over-year basis. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were paid a $0.03 dividend. The ex-dividend date of this dividend was Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

Insider Activity at GE HealthCare Technologies

In other news, insider Frank R. Jimenez bought 1,315 shares of the business’s stock in a transaction that occurred on Wednesday, May 1st. The stock was acquired at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the purchase, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other GE HealthCare Technologies news, CEO Jan Makela sold 20,227 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Frank R. Jimenez purchased 1,315 shares of the stock in a transaction on Wednesday, May 1st. The stock was bought at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the acquisition, the insider now owns 75,796 shares in the company, valued at $5,799,909.92. The disclosure for this purchase can be found here. 0.27% of the stock is currently owned by company insiders.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.